Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Global Utilization of Streptokinase and

GUSTO Global Utilization of Streptokinase and Tissue plasminogen activator for Occluded coronary arteries... [Pg.534]

Crenshaw BS, Granger CB, Birnbaum Y, et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-1 (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation 2000 101(1 ) 27—32. [Pg.602]

Tsang TS, Califf RM, Stebbins AL, Lee KL, Cho S, Ross AM, Armstrong PW. Incidence and impact on outcome of streptokinase allergy in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries. Am J Cardiol 1997 79(9) 1232-5. [Pg.3408]

Barbash Gl, Bimbaum Y, Bogaerts K, Hudson M, Lesaffre E, Fu Y, Goodman S, Houbracken K, Munsters K, Granger CB, Pieper K, Califf RM, Topol EJ, Van De Werf E. Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies. Circulation 2001 103 954-960. [Pg.27]

Califf RM, White HD, Van de Werf F, et al. One year results from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO-I) trial. Circulation 1996 94 1233-1238. [Pg.62]

Labinaz M, Sketch MH, Ellis SG, et al. for the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries trial (GUSTO-I). Outcome of acute ST-segment elevation myocardial infarction in patients with prior coronary artery bypass surgery receiving thrombolytic therapy. Am Heart J 2001 141 469-477. [Pg.109]

Topol EJ, Ohman EM, Armstrong PW, Wilcox R, Skene AM, Aylward P, Simes J, Dalby A, Betriu A, Bode C, White HD, Hochman JS, Emanuelson H, Vahanian A, Sapp S, Stebbins A, Molitemo DT, Califf RM. Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial. Circulation 2000 102 1761-1765. [Pg.226]

White HD, Barbash GI, Califf RM, Simes RJ, Granger CB, Weaver WD, Kleiman NS, Aylward RP, Gore JM, Vahanian A, Lee KL, Ross AM, Topol EJ. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation 1996 94 1826-1833. [Pg.226]

See other pages where Global Utilization of Streptokinase and is mentioned: [Pg.50]    [Pg.252]    [Pg.255]    [Pg.315]    [Pg.315]    [Pg.322]    [Pg.133]    [Pg.215]    [Pg.227]    [Pg.131]    [Pg.135]    [Pg.50]    [Pg.252]    [Pg.255]    [Pg.315]    [Pg.315]    [Pg.322]    [Pg.133]    [Pg.215]    [Pg.227]    [Pg.131]    [Pg.135]   


SEARCH



Streptokinase

© 2024 chempedia.info